Darren Cunningham

Irish drug developer signs licensing deal for autoimmune therapies

Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics

Mon Aug 21 2023 - 18:45

Dublin pharma development company’s drug blocks pathways used by cancer cells

Thu Jul 18 2019 - 09:46

Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer

Fri Apr 13 2018 - 06:02

Fri Jan 24 2014 - 00:00

A pharmaceuticals expert and business development adviser have joined to run a cancer-drug research company from a home office

Mon Jul 15 2013 - 01:00